Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Rohof, R. Bennink, A. Smout, E. Thomas, G. Boeckxstaens (2013)
An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 11 12
A. Leodolter, M. Nocon, M. Vieth, T. Lind, D. Jaspersen, K. Richter, S. Willich, M. Stolte, P. Malfertheiner, J. Labenz (2012)
Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD studyScandinavian Journal of Gastroenterology, 47
P. Labenz, C. Labenz (2016)
Gastroenterologische Erkrankungen als Auslöser von ThoraxschmerzDer Internist, 58
J. Labenz, H. Koop (2017)
Gastroösophageale Refluxkrankheit — was tun, wenn PPI nicht ausreichend wirksam, verträglich oder erwünscht sind?Dtsch med Wochenschr, 142
J. Dent (2007)
Microscopic esophageal mucosal injury in nonerosive reflux disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 5 1
S. Gaddam, S. Wani, H. Ahmed, P. Maddur, S. Hall, N. Gupta, S. Puli, A. Higbee, A. Rastogi, A. Bansal, P. Sharma (2010)
The impact of pre‐endoscopy proton pump inhibitor use on the classification of non‐erosive reflux disease and erosive oesophagitisAlimentary Pharmacology & Therapeutics, 32
P. Bytzer, Roger Jones, N. Vakil, O. Junghard, T. Lind, B. Wernersson, J. Dent (2012)
Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 10 12
M. Desjardin, S. Roman, S. Varannes, G. Gourcerol, B. Coffin, A. Ropert, F. Mion, F. Zerbib (2013)
Pharyngeal pH alone is not reliable for the detection of pharyngeal reflux events: A study with oesophageal and pharyngeal pH-impedance monitoringUnited European Gastroenterology Journal, 1
N. Vakil, S. Zanten, P. Kahrilas, J. Dent, Roger Jones (2006)
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based ConsensusThe American Journal of Gastroenterology, 101
P. Malfertheiner, M. Nocon, M. Vieth, M. Stolte, D. Jaspersen, H. Koelz, J. Labenz, A. Leodolter, T. Lind, K. Richter, S. Willich (2012)
Evolution of gastro‐oesophageal reflux disease over 5 years under routine medical care – the ProGERD studyAlimentary Pharmacology & Therapeutics, 35
H. Koop, K.H. Fuchs, J. Labenz (2014)
S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013Z Gastroenterol, 52
J. Labenz, C. Labenz (2016)
Prävalenz und natürlicher Verlauf der gastroösophagealen RefluxkrankheitDer Gastroenterologe, 11
R. Hunt, Y. Yuan, C. Scarpignato (2014)
Editorial: healing of refractory reflux oesophagitis – an ongoing unmet clinical needAlimentary Pharmacology & Therapeutics, 40
Prateek Sharma, J. Dent, D. Armstrong, J. Bergman, L. Gossner, Y. Hoshihara, J. Jankowski, O. Junghard, L. Lundell, G. Tytgat, M. Vieth (2006)
The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.Gastroenterology, 131 5
E. Ness-Jensen, A. Lindam, J. Lagergren, K. Hveem (2013)
Weight Loss and Reduction in Gastroesophageal Reflux. A Prospective Population-Based Cohort Study: The HUNT StudyThe American Journal of Gastroenterology, 108
H. El‐Serag, Stephen Sweet, C. Winchester, J. Dent (2013)
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic reviewGut, 63
S. Roman, C. Gyawali, E. Savarino, R. Yadlapati, F. Zerbib, J. Wu, M. Vela, R. Tutuian, R. Tatum, D. Sifrim, J. Keller, M. Fox, J. Pandolfino, A. Bredenoord, F. Azpiroz, A. Babaei, S. Bhatia, G. Boeckxstaens, S. Bor, D. Carlson, D. Castell, M. Cicala, J. Clarke, N. Bortoli, V. Drug, M. Frazzoni, R. Holloway, P. Kahrilas, A. Kandulski, P. Katz, D. Katzka, R. Mittal, F. Mion, L. Novais, Amit Patel, R. Penagini, M. Ribolsi, J. Richter, R. Salvador, V. Savarino, J. Serra, F. Schnoll-Sussman, A. Smout, E. Soffer, R. Sweis, J. Tack, S. Tolone, M. Vaezi, P. Woodland, Yinglian Xiao (2017)
Ambulatory reflux monitoring for diagnosis of gastro‐esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus groupNeurogastroenterology & Motility, 29
J. Labenz (2016)
Barrett’s esophagusInternist, 57
W. Fischbach, P. Malfertheiner, P. Jansen, W. Bolten, J. Bornschein, S. Buderus, E. Glocker, J. Hoffmann, S. Koletzko, J. Labenz, J. Mayerle, S. Miehlke, J. Mössner, U. Peitz, C. Prinz, M. Selgrad, S. Suerbaum, M. Venerito, M. Vieth, W. Fischbach (2016)
S2k-Guideline Helicobacter pylori and gastroduodenal ulcer diseaseZeitschrift für Gastroenterologie, 55
G. Boeckxstaens, H. El‐Serag, A. Smout, P. Kahrilas (2014)
Symptomatic reflux disease: the present, the past and the futureGut, 63
J. Dent, N. Vakil, Roger Jones, P. Bytzer, U. Schöning, K. Halling, O. Junghard, T. Lind (2010)
Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond StudyGut, 59
M. Kulig, M. Nocon, M. Vieth, A. Leodolter, D. Jaspersen, J. Labenz, W. Meyer-Sabellek, M. Stolte, T. Lind, P. Malfertheiner, S. Willich (2004)
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study.Journal of clinical epidemiology, 57 6
H. El‐Serag, A. Becher, Roger Jones (2010)
Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studiesAlimentary Pharmacology & Therapeutics, 32
R. Schey, R. Dickman, S. Parthasarathy, S. Quan, C. Wendel, Jonah Merchant, J. Powers, Bing Han, Daniel Handel, R. Fass (2007)
Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease.Gastroenterology, 133 6
J. Labenz (2010)
Facts and fantasies in extra-oesophageal symptoms in GORD.Best practice & research. Clinical gastroenterology, 24 6
C. Reimer, A. Lødrup, Gary Smith, J. Wilkinson, P. Bytzer (2016)
Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add‐on therapy in reflux patients with inadequate response to a once daily proton pump inhibitorAlimentary Pharmacology & Therapeutics, 43
W. Fischbach, P. Malfertheiner, P. Lynen Jansen (2016)
S2k-Leitlinie Helicobacter pylori und gastroduodenale UlkuskrankheitZ Gastroenterol, 55
M. Vaezi, J. Pandolfino, M. Vela, N. Shaheen (2017)
White Paper AGA: Optimal Strategies to Define and Diagnose Gastroesophageal Reflux Disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 15 8
P. Labenz (2016)
Barrett-ÖsophagusDer Internist, 57
N. Manabe, K. Haruma, Masanori Ito, N. Takahashi, H. Takasugi, Y. Wada, H. Nakata, T. Katoh, M. Miyamoto, S. Tanaka (2012)
Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 25 5
Herbert Koop, P. Jansen, Karl-Hermann Fuchs, Mitarbeiter Leitliniengruppe, Joachim Labenz, T. Wenzl, Helmut Messmann, W. Schepp, S. Miehlke (2014)
S2k-Leitlinie: Gastroösophageale Refluxkrankkheit unter Federführung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)Zeitschrift für Gastroenterologie, 52
B. Weusten, R. Bisschops, E. Coron, M. Dinis-Ribeiro, J. Dumonceau, J. Esteban, C. Hassan, O. Pech, A. Repici, J. Bergman, M. Pietro (2017)
Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position StatementEndoscopy, 49
J. Krugmann, H. Neumann, M. Vieth, D. Armstrong (2013)
What is the role of endoscopy and oesophageal biopsies in the management of GERD?Best practice & research. Clinical gastroenterology, 27 3
J. Labenz, H. Koop (2017)
Gastroösophageale Refluxkrankheit – was tun, wenn PPI nicht ausreichend wirksam, verträglich oder erwünscht sind?DMW - Deutsche Medizinische Wochenschrift, 142
Die GERD ist eine typische Spektrumerkrankung mit gelegentlichen Refluxbeschwerden auf der einen und schweren, mitunter tödlich verlaufenden Manifestationen wie dem Barrett-Karzinom auf der anderen Seite. Erschwerend kommt hinzu, dass sich die Krankheit in zahlreichen Symptomen und Läsionen inner- und außerhalb der Speiseröhre manifestieren kann. Verschiedene klinische Szenarien erfordern unterschiedliche Abklärungsstrategien.
Gastro-News – Springer Journals
Published: Dec 1, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.